MEDICAL GROUP MANAGEMENT ASSN for MEDICAL GROUP MANAGEMENT ASSN
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare payment reform - Submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) proposed 2025 Medicare Physician Fee Schedule (PFS); joined letter to congressional leadership on the need for Medicare physician payment reform before the end of the year; joined letter to congressional leadership on the need to reform the Medicare Access and CHIP Reauthorization Act. Value-based care - Joined letter to CMS on the Medicare Shared Savings Program provisions of its proposed 2025 PFS; joined letter to CMS about its proposed rule on mitigating the impact of significant, anomalous, and highly suspect billing activity on Medicare Shared Savings Program Financial Calculations in Calendar Year 2023. Telehealth - Submitted testimony on telehealth in response to the House Committee on Energy and Commerces markup of 16 bills; joined letter to the Congress and the White House about extending current flexibilities regarding prescribing controlled substances via telehealth. Prior Authorization - Joined letter to Congress in support of the Electronic Prior Authorization for Prescription Drugs Act (S. 4349). Cybersecurity - Submitted comments in response to the Department of Homeland Securitys proposed rule on the Cyber Incident Reporting for Critical Infrastructure Acts reporting requirements. Medical debt - Submitted comments in response to the Consumer Financial Protection Bureaus proposed rule on medical debt.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDERS GILBERG | — |
| JAMES HAYNES | — |
Health Issues HCR
Medicare payment reform - Submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) proposed 2025 Medicare Physician Fee Schedule (PFS); joined letter to congressional leadership on the need for Medicare physician payment reform before the end of the year; joined letter to congressional leadership on the need to reform the Medicare Access and CHIP Reauthorization Act. Value-based care - Joined letter to CMS on the Medicare Shared Savings Program provisions of its proposed 2025 PFS; joined letter to CMS about its proposed rule on mitigating the impact of significant, anomalous, and highly suspect billing activity on Medicare Shared Savings Program Financial Calculations in Calendar Year 2023. Telehealth - Submitted testimony on telehealth in response to the House Committee on Energy and Commerces markup of 16 bills; joined letter to the Congress and the White House about extending current flexibilities regarding prescribing controlled substances via telehealth. Prior Authorization - Joined letter to Congress in support of the Electronic Prior Authorization for Prescription Drugs Act (S. 4349). Cybersecurity - Submitted comments in response to the Department of Homeland Securitys proposed rule on the Cyber Incident Reporting for Critical Infrastructure Acts reporting requirements. Medical debt - Submitted comments in response to the Consumer Financial Protection Bureaus proposed rule on medical debt.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDERS GILBERG | — |
| JAMES HAYNES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.